Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients
In addition, PEGylation reduces the clearance of protein drugs by reticuloendothelial tissue, shields antigenic determinants, reduces immune system recognition, and prevents degradation by proteolytic enzymes
Regular monitoring and open communication with your medical team will help mitigate these risks
Clothing rubbing against the body becomes painful
Follow your trial team's guidance on glucose monitoring and dose adjustment
US$ 20.67
US$ 20.07
US$ 20.10
US$ 20.71
